Viewing Opinion | StockChase
Merck & Company (MRK-N) opinion on 2009-09-04

Last Price Recorded: 54.2700 on 2017-11-21

ON STOCKCHASE SINCE Oct 2000

biotechnology/pharmaceutical
COMMENT

Andrew Guy, CFA
Merck & Company was $30.700 at time of opinion
Owned : Unknown

Pharmaceutical. More disciplined approach so they've been generating very strong free cash flow. A couple of their strong drugs will be coming off patent in a couple of years. In the process of merging with Schering-Plough (SGP-N). If you were going to pick a name, he would prefer Abbott (ABT-N). 5% dividend yield.
OPTIMISTIC

All opinions for MRK-N (162)

35 BUY
13 COMMENT
44 DON'T BUY
6 HOLD
22 PAST TOP PICK
4 SELL
1 STRONG BUY
25 TOP PICK
2 WAIT
10 WEAK BUY
View All

More experts covering MRK-N

SAVE
Add MRK-N to Watch List

All opinions for MRK-N (162)

35 BUY
13 COMMENT
44 DON'T BUY
6 HOLD
22 PAST TOP PICK
4 SELL
1 STRONG BUY
25 TOP PICK
2 WAIT
10 WEAK BUY
View All

More experts covering MRK-N

SAVE
Add MRK-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company